{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:31:05Z","timestamp":1783114265402,"version":"3.54.6"},"reference-count":62,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ear Nose Throat J"],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are a rapidly proliferating class of drugs used for diabetes and obesity management. Their use poses several implications for ear, nose and throat (ENT) surgeons, including high-risk airway surgery considerations. This review highlights pharmacological mechanisms, ENT-specific side effects and perioperative challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A narrative review was performed with comprehensive literature search across PubMed and Google Scholar (2000-2025). International anaesthetic, surgical and endoscopic guidelines were reviewed and synthesised to compare management strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>GLP-1 RAs function to regulate glucose, reduce appetite and slow gastric emptying, increasing aspiration risk during airway surgery. ENT clinical implications include patulous eustachian tube dysfunction, nasopharyngitis and improvement in sleep apnoea and emerging sinus surgery outcomes. Pre-clinical data suggest a theoretical medullary thyroid cancer risk. Despite endoscopy data showing increased residual gastric content, no studies specifically address risks in airway surgery. Peri-operative guidelines vary, and this review reports the range of recommendations from major international anaesthetic organisations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>ENT surgeons must recognise GLP-1 RA associated risks, especially during tubeless airway surgery. An individualised, team-based approach may be necessary for patients, as current guidelines do not reach consensus. ENT side effects of eustachian tube dysfunction, and theoretical risk of medullary thyroid cancer still needs further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/01455613261445013","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:29:58Z","timestamp":1778070598000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["GLP-1 Receptor Agonists in Ear, Nose and Throat: A Review of Clinical Implications, Side Effects and High-Risk Airway Surgery Considerations"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8673-1408","authenticated-orcid":false,"given":"Sivagowri","family":"Somasundaram","sequence":"first","affiliation":[{"name":"ENT Department, Townsville University Hospital, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9923-2087","authenticated-orcid":false,"given":"James","family":"Nightingale","sequence":"additional","affiliation":[{"name":"ENT Department, Townsville University Hospital, QLD, Australia"},{"name":"ENT Department, Queensland Children\u2019s Hospital, South Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2152-8379","authenticated-orcid":false,"given":"Subhapriya","family":"Sreedharan","sequence":"additional","affiliation":[{"name":"Anaesthetic Department, Townsville University Hospital, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1485-3744","authenticated-orcid":false,"given":"Claire","family":"Frauenfelder","sequence":"additional","affiliation":[{"name":"ENT Department, Queensland Children\u2019s Hospital, South Brisbane, QLD, Australia"},{"name":"Child Health Research Centre, The University of Queensland, South Brisbane, QLD, Australia"},{"name":"Deadly Ears Indigenous Health Program, Children\u2019s Health Queensland, South Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000001348"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52582"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/lary.31214"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-018-0038-0"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.03.001"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.09.010"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16306"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000006810"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2023.111091"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2017.05.009"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-025-02079-9"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2024.01.001"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2024.11.025"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-023-02550-y"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/ans.18804"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/ohbm5020012"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12090224"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2404881"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/lary.70022"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2024.4593"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/lary.32061"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2407"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2024.4852"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.925377"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-025-09604-5"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000004373"},{"issue":"3","key":"e_1_3_2_28_2","first-page":"202","article-title":"Adverse effects of GLP-1 receptor agonists","volume":"11","author":"Filippatos TD","year":"2015","unstructured":"Filippatos TD, Panagiotopoulou TV, Elisaf MS. Adverse effects of GLP-1 receptor agonists. Rev Diabet Stud. 2015; 11(3):202.","journal-title":"Rev Diabet Stud"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ohn.70072"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2024.0111"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13216336"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14164"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpaic.2007.07.011"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/56.1.37"},{"issue":"7","key":"e_1_3_2_35_2","article-title":"Anesthesia considerations for a patient on semaglutide and delayed gastric emptying","volume":"15","author":"Fujino E","year":"2023","unstructured":"Fujino E, Cobb KW, Schoenherr J, Gouker L, Lund E. Anesthesia considerations for a patient on semaglutide and delayed gastric emptying. Cureus. 2023;15(7):e42153.","journal-title":"Cureus"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-023-02521-3"},{"issue":"4","key":"e_1_3_2_37_2","first-page":"171","article-title":"Aspiration under anaesthesia: risk assessment and decision-making","volume":"14","author":"Robinson M","year":"2014","unstructured":"Robinson M, Davidson A. Aspiration under anaesthesia: risk assessment and decision-making. Continuing Educ Anaesth Crit Care Pain. 2014;14(4):171-175.","journal-title":"Continuing Educ Anaesth Crit Care Pain"},{"key":"e_1_3_2_38_2","volume-title":"The Fasting and the Furious: Reconciling Fasting Guidelines with Glucagon-Like Peptide-1 Receptor Agonists,\u2018Sip-til-Send\u2019 Policies and Gastric Ultrasound","author":"Sidhu N","year":"2025","unstructured":"Sidhu N, Hogg R. The Fasting and the Furious: Reconciling Fasting Guidelines with Glucagon-Like Peptide-1 Receptor Agonists,\u2018Sip-til-Send\u2019 Policies and Gastric Ultrasound. Wiley Online Library; 2025."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000005204"},{"key":"e_1_3_2_40_2","unstructured":"Clinical Practice Recommendations regarding patients taking GLP-1 receptor agonists and dual GLP-1\/GIP receptor co-agonists prior to anaesthesia or sedation for surgical and endoscopic procedures. 2025. https:\/\/www.anzca.edu.au\/safety-and-advocacy\/standards-of-practice\/clinical-practice-recommendations-regarding-patients-taking-glp-1"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16601"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52170"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.07.021"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.03.013"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.03.015"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.0081"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.5003"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2024.12.019"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-024-11263-2"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2024.10.011"},{"key":"e_1_3_2_51_2","unstructured":"Clinical Practice Recommendation on Periprocedural Use of GLP-1\/GIP Receptor Agonists. 2024. https:\/\/www.diabetessociety.com.au\/resource-periprocedural-use-glp1-gip-ras-june-2024\/"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000005231"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16541"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000001914"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeu151"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-013-9974-y"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aev113"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06718-0"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.7.2212"},{"issue":"1","key":"e_1_3_2_60_2","article-title":"Gastric ultrasound to assess the prokinetic efficacy of erythromycin in a patient taking glucagon-like peptide-1 receptor agonists","volume":"13","author":"Sidhu N.","year":"2025","unstructured":"Sidhu N. Gastric ultrasound to assess the prokinetic efficacy of erythromycin in a patient taking glucagon-like peptide-1 receptor agonists. Anaesth Rep. 2025;13(1):e70008.","journal-title":"Anaesth Rep"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.12.030"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/bjaed\/mkx004"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.17085\/apm.23014"}],"container-title":["Ear, Nose &amp; Throat Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/01455613261445013","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/01455613261445013","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/01455613261445013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T07:17:53Z","timestamp":1778397473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/01455613261445013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":62,"alternative-id":["10.1177\/01455613261445013"],"URL":"https:\/\/doi.org\/10.1177\/01455613261445013","relation":{},"ISSN":["0145-5613","1942-7522"],"issn-type":[{"value":"0145-5613","type":"print"},{"value":"1942-7522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"article-number":"01455613261445013"}}